NCT03363386

Brief Summary

The aim of the study is to investigate proprioceptive exercises training combined with aerobic exercises and resistive exercises training combined with aerobic exercises on dynamic balance and superficial sense. The patients were randomly divided into Proprioceptive Exercise Training Group (PG) (n=15) and Resistive Exercise Training Group (RG) (n=15). All subjects were included exercise education program and both groups had trained aerobic exercise program for walking on treadmill (2times/wk. 6 week duration).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 6, 2017

Completed
Last Updated

December 6, 2017

Status Verified

December 1, 2017

Enrollment Period

1 month

First QC Date

November 10, 2017

Last Update Submit

December 5, 2017

Conditions

Keywords

aerobic exercisedynamic balancefunctional capacityHbA1cproprioceptive exercise training

Outcome Measures

Primary Outcomes (9)

  • Change in HbA1c level

    It was evaluated for metabolic control with patient's routine controls in their clinics follow-up. At the end of the study, this metabolic variable was evaluated again in order to observe changes

    6 weeks

  • Waist and Hip Circumferences

    It represents risks for cardiovascular diseases.

    6 weeks

  • Six minute walking test

    Functional capacity of the patients was evaluated through 6 minute walking test

    6 weeks

  • Dynamic balance assessment

    Prokin PK 200 was used for dynamic balance assessment

    6 weeks

  • Vibration Perception Threshold Assessment

    Biothesiometer was used for determining vibration perception threshold

    6 weeks

  • Lower Extremity Muscle Strength

    Commander myometer was used for muscle strength assessment

    6 weeks

  • Proprioception Assesment

    Angle reproduction test was used

    6 weeks

  • Two Point Discrimination Test

    aesthesiometer was used to determine two point discrimination sensation

    6 weeks

  • Change in fasting blood glucose level

    It was evaluated for metabolic control with patient's routine controls in their clinics follow-up. At the end of the study, this metabolic variable was evaluated again in order to observe changes

    6 weeks

Study Arms (2)

Proprioceptive Exercise Group (PG)

EXPERIMENTAL

Aerobic Exercise Proprioceptive Exercises

Procedure: Proprioceptive ExercisesProcedure: Aerobic Exercise

Resistive Exercise Group (RG)

ACTIVE COMPARATOR

Aerobic Exercise Resistive Exercises

Procedure: Resistive ExercisesProcedure: Aerobic Exercise

Interventions

Patients trained for proprioceptive exercises

Proprioceptive Exercise Group (PG)

Patients trained for resistive exercises

Resistive Exercise Group (RG)

Patients were educated with treadmill walking for 30 minutes of each exercise session

Proprioceptive Exercise Group (PG)Resistive Exercise Group (RG)

Eligibility Criteria

Age30 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participating to the study in a voluntary basis
  • Patients with 30-60 years old
  • Getting diagnosed with Type 2 Diabetes Mellitus (DM) at least 6 months.

You may not qualify if:

  • Unstable cardiac condition
  • Uncontrolled Diabetes Mellitus
  • Uncontrolled Hypertension
  • Symptomatic Heart Failure, unstable angina
  • Peripheral Arterial Occlusive Disease
  • Diabetic foot ulcers
  • Part/total foot amputation
  • Myocardial infarction within 3 months prior to study
  • Coronary Artery Bypass within 3 months prior to study
  • Cerebrovascular ischemia/stroke (including TIA) within 3 months of study
  • Severe retinopathy, nephropathy
  • Thyroid Dysfunctions (hyperthyroidism, hypothyroidism).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Exercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Guzin Kaya Aytutuldu, M.Sc.

    Yeditepe University, Health Sciences Faculty, Department of Physiotherapy and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • Feryal Subasi, Professor

    Yeditepe University, Health Sciences Faculty, Department of Physiotherapy and Rehabilitation

    STUDY CHAIR
  • Gülgün Arslan, MD

    Istanbul Pendik Kaynarca Outpatient Policlinic Diabetes Center

    STUDY CHAIR
  • Elif Develi, M.Sc.

    Yeditepe University, Health Sciences Faculty, Department of Physiotherapy and Rehabilitation

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The sample of study consists of patients with Type 2 Diabetes Mellitus (DM) got diagnosed at least 6 months and who referred to Fitness Center in Pendik Arif Nihat Asya Kültür Merkezi Istanbul Turkey by a medical doctor between December 2016- March 2017. The study included in 30 patients (24F, 6M) with T2DM. The patients who met inclusion criteria are divided into two groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 10, 2017

First Posted

December 6, 2017

Study Start

December 1, 2016

Primary Completion

January 1, 2017

Study Completion

March 1, 2017

Last Updated

December 6, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share